The International Society of Anti-Infective Pharmacology is an interdisciplinary scientific society for the study of pharmacodynamics and pharmacokinetics and for the improvement of dosing of anti-infectives. The Society efforts are focused on expanding basic and applied knowledge in this area of chemotherapeutics through the organization of symposia, discussion workshops , and educational workshops with international participation, in connection with major scientific meetings dealing with the chemotherapy of infectious diseases (ASM microbe, ICC, ECCMID ...), and other scientific societies with common interests, and Regulatory Authorities (FDA, EMA).
2023 ISAP Annual Meeting in Copenhagen
The ISAP Annual Meeting is now open for registration. Please register here before 10 March 2023 for catering purposes.
Attendance is free of charge for ISAP members. Please ensure that you have renewed your membership to be eligible. Click here to renew your membership.
Date: 14th April 2023 (Friday)
Time: 9.30am to 2pm
Venue: Scandic Palace (Rådhuspladsen 57, 1550 Copenhagen V)
9.30am - 10.00am: Registration and breakfast buffet
10.00am - 10.10am: Welcome note
10.10am - 10.50am: Keynote speaker (Professor Oana Ciofu, University of Copenhagen)
10.50am - 12.30pm: Young investigator's talk
12.30pm - 1.15pm: Lunch
1.15pm - 2.00pm: General meeting, award presentation and closing
We hope to see you in Copenhagen soon!
Postdoc positions available:
The PKPD group at Uppsala University is searching for a devoted postdoc who is enthusiastic about antimicrobial PKPD, and has experience in model-based methods. More info:https://www.uu.se/en/about-uu/join-us/details/?positionId=593734
PhD Student (3 yrs.) - University of Hamburg, Germany
The Dept. of Clinical Pharmacy at the University of Hamburg, Germany, is hiring a PhD student. The anticipated starting date is May 2023, but the exact date can be defined individually. The project is embedded in a EU consortium that focuses on optimizing the therapy of ceftazidime/avibactam and fosfomycin against Enterobacterales (JPIAMR - CAVIFOS, https://www.jpiamr.eu/projects/cavifos/). The PhD project will involve pharmacokinetic-pharmacodynamic studies in the hollow-fiber infection model as well as pharmacometric modelling and development of model-informed precision dosing tools to translate the findings into a clinical perspective.